fitness news
Font size Women’s Health
Chemotherapy: What Does It Really Do?
– Reported, April 05, 2013
(Ivanhoe Newswire) — We think we know, but do really understand chemotherapy? It’s generally thought that anticancer chemotherapies works like antibiotics do, by directly killing off what’s harmful. But new research shows that effective chemotherapies actually work by mobilizing the body’s own immune cells to fight cancer.
Researchers found that chemo-treated dying tumors secrete a factor that attracts certain immune cells, which then ingest tumor proteins and present them on their surfaces as alert signals that an invader is present. This new understanding of how chemotherapy works with our immune systems could prompt new tactics for treating cancer.
“Successful chemotherapeutics convert the tumor into a therapeutic vaccine, hence mobilizing the host’s immune system against the cancer,” senior author Dr. Guido Kroemer, of the Institut Gustave Roussy, in France, was quoted as saying.
Dr. Kroemer and his colleagues found that when chemotherapy kills and bursts open cancer cells, the cells release a factor called ATP. The factor recruits immune cells to the tumor site, where they are educated to acquire their functionnamely, to ingest and present tumor proteins on their surfaces. The researchers found that when these trained immune cells are blocked, chemotherapy (specifically, anthracyclines) cannot efficiently reduce the growth of tumors in mice. Also, when these trained immune cells are injected into other mice, the mice can fight off cancer cells that are subsequently injected.
The findings point to a new strategy to improve cancer treatments. “Anticancer therapies and immunotherapies might be combined in a way to optimize the local recruitment and function of immune cellsfor instance, by increasing extracellular ATP levelswith the goal of boosting the chemotherapy-induced anticancer immune response,” says Dr. Kroemer. Also, measuring the recruitment of immune cells to tumor sites after chemotherapy might help predict how well a patient’s cancer will respond to the treatment.
SOURCE: Cell Press Journal Immunity, April 2013